Brief: Medicure Announces Settlement of Patent Infringement Action
18/11/2020 23:02
Nov 18 (Reuters) - Medicure Inc MPH.V :
* MEDICURE INC - SETTLED ITS ONGOING PATENT INFRINGEMENT
ACTION
AGAINST NEXUS PHARMACEUTICALS, INC
* MEDICURE INC - SETTLEMENT RESULTS IN COMPANY ENTERING INTO
A
LICENSE AGREEMENT WITH NEXUS
* MEDICURE INC - REMAINING TERMS OF SETTLEMENT ARE
CONFIDENTIAL
Source text for Eikon: ID:nCNWb5kHSa
Further company coverage: MPH.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicure
See all newsBrief: Medicure Announces Resignation Of Board Member And Grant Of Stock Options
Brief: Medicure Posts Qtrly Earnings Per Share $0.11
Brief: Medicure Reports Financial Results For Quarter Ended June 30, 2022
Brief: Medicure Announces Resignation Of CFO And Succession Plan
Brief: Algernon Pharmaceuticals Appoints James Kinley As CFO Effective From December 1, 2021